Aims: The objective of this paper was to review our institution ' s cesarean delivery rates starting in 2004 prior to the full implementation of a patient safety program including a uniform oxytocin policy until 2012 when the oxytocin policy and the safety program had been fully implemented. Results: Cesarean delivery rates at our institution decreased incrementally from 41.6 % in 2004 to 32.7 % in 2012. The decrease in cesarean delivery rates was observed for each of the fi ve age groups. Conclusion: Concerns about an increase in cesarean delivery rates after implementation of a comprehensive patient safety program including a standardized oxytocin protocol may be unfounded. Despite the increase of US national cesarean delivery rates, our study shows that it is possible to safely lower cesarean delivery rates without concomitant concerns of litigations.
Introduction
Improving patient safety on labor and delivery has become an important goal for hospitals, physicians, patients, and insurers. These improvements require changes in physicians ' behaviors. The slow progress in implementing patient safety has been blamed on physicians ' culture of professional autonomy and the perception by physicians that implementing patient safety measures is a threat to their autonomy and independence [21] .
In 2003, we started to implement a stepwise comprehensive patient safety program (Table 1 ) which included a uniform oxytocin policy (begun in 2005) and other changes, and which in due course showed an eventual decrease in compensation payments [12] .
The objective of this paper was to review our institution ' s cesarean delivery rates starting in 2004 prior to the full implementation of a uniform oxytocin policy and patient safety program until 2012 when the oxytocin policy and the safety program had been fully implemented. Our hypothesis was that cesarean delivery rates would be unchanged over the time period of the study.
Materials and methods
Data for this study were obtained from the medical records ' database of 45,655 consecutive deliveries at the New York Weill Cornell Medical Center between January 1, 2004, and August 31, 2012.
In 2003, we instituted a comprehensive incremental patient safety program (see Table 1 ) which included the use of a uniform protocol for oxytocin induction or stimulation of labor which began in 2005 [12] . The protocol included the use of low-dose oxytocin with a uniform starting dose and a fi xed rate of increase (start at 1 mU/min; increase at 1 mU/min no more frequently than every 15 min) as well as of decrease or stopping the oxytocin when tachysystole was present. In addition, because of concerns for tachysystole, we have not used misoprostol in a live viable fetus. We allow scheduled labor induction without adequate medical indication only after 39 completed weeks of gestation (39 weeks 0 days or after). Labor induction prior to 39 completed weeks must have a clearly defi ned indication.
For this study we included all consecutive deliveries that occurred at our institution from January 1, 2004 
Results
There were a total of 45,655 deliveries between January 1, 2004, and August 31, 2012. Table 2 and Figures 1 and 2 summarize the cesarean delivery rates by calendar year and age groups. Cesarean delivery rates from all patients decreased incrementally from 41.6 % in 2004 to 32.7 % in 2012 (P < 0.001). The decrease in cesarean delivery rates was observed for each of the fi ve age groups. Patients whose age was 40 years and more had the highest cesarean delivery rates, whereas patients under 25 years of age had the lowest cesarean delivery rates.
Conclusions
Cesarean delivery rates have increased signifi cantly over the last 2 decades in individual institutions [2] and have continued to rise in the United States from 22.7 % in 1990, to 27.5 % in 2003, and to 32.8 % in 2010 [20] .
The cause of the increase in cesarean delivery rates is multifactorial [2, 15, 17] . Our fi ndings show that, contrary to misconceptions about patient safety programs, cesarean delivery rates do not necessarily have to increase but can actually decrease with the implementation of a comprehensive patient safety program including a low-dose uniform oxytocin protocol.
One of the main aspects of our safety program was an implementation of a uniform low-dose oxytocin protocol in 2005 [12] . Although standardized and uniform practice patterns are known to have better outcomes than greater practice variations [7, 13, 25] , medical practice continues to be characterized by wide variations that have little basis in clinical science [26] .
Oxytocin, the most frequently used intravenous medication in obstetric practice, is among the drugs known to be used in many variations. For example, the ACOG bulletin on augmentation of labor lists at least six different acceptable uses of low-dose and high-dose oxytocin regimens with starting doses of between 0.5 and 6 mU/min, incremental doses ranging from 1 to 6 mU/min, and dosage intervals from 15 to 40 min [1] . The list of options includes several high-dose regimens, although they have been found to be associated with more uterine hyperstimulation than low-dose regimens [4, 10, 19, 22, 23] .
Considering that the use of oxytocin during labor and delivery can lead to uterine tachysystole (previously hyperstimulation) [24] , that it has been found to have a negative impact on the probability of successfully defending a professional [9] , and its use, especially its misuse, has been alleged to be responsible for many, if not most of, adverse outcomes and professional liability suits involving abnormal labor [3, 5, 14] , it is surprising that so many variations continue to be in use despite our knowledge that standardized patterns are safer than many variations.
The main objectives of developing a standardized oxytocin protocol at our institution were to decrease exposure to professional liability, to decrease the incidence of hyperstimulation, and to reduce the risks to patients. After instituting the protocol, fetal heart rate tracing reviews consistently showed a decrease in uterine tachysystole and there were less claims and payouts between 2003 and 2009 [12] .
In this study, we showed that cesarean delivery rates at our institution decreased from 41.6 % in 2004 before the full implementation of a comprehensive patient safety program to 32.7 % in 2012 after the implementation of the comprehensive patient safety program, including a standardized low-dose oxytocin protocol and no use of misoprostol in a live viable fetus.
This decrease in cesarean delivery rates is similar to that reported by Clark et al. [6] who observed a reduction of primary cesarean delivery rates after the implementation of a checklist-based oxytocin protocol.
There are several possible reasons for the decrease in cesarean delivery rates which we observed. The introduction of our oxytocin protocol geared toward prevention and prompt attention to uterine tachysystole may have resulted in a decreased incidence of uterine tachysystole with resultant decreased cesarean deliveries for non-reassuring fetal heart rate tracings. Abnormal fetal heart rate tracings are among the main indications for cesarean deliveries of women in labor, and uterine tachysystole with oxytocin leads to an increase in abnormal fetal heart rate tracing patterns [18] , whereas less oxytocin is associated with less uterine hyperstimulation [10, 13, 18] . In addition, standardization of the oxytocin protocol and the standardized use of the term " uterine tachysystole " (previously hysterstimulation), defi ned as more than fi ve uterine contractions within a 10-min window [16] , could have prevented overinterpretation of tracings and unnecessary cesarean deliveries. Finally, empowering the nursing staff and enhancing their autonomy allowed for a more expeditious stoppage and titration of oxytocin in labor, which resulted in the prevention of non-reassuring fetal heart rate tracings following uterine tachysystole.
A strength of our study is that we had 45,655 consecutive deliveries in a single institution over a 9-year time period showing the decrease in cesarean delivery rates with a welldocumented patient safety program.
A weakness of our study is that we did not have additional individual data on our patients. However, we showed that the decrease in cesarean delivery rates was seen across all age groups and years, and we believe that there were no signifi cant changes in our patient characteristics over the time period of this study which may have lowered the cesarean delivery rates.
One of the confounding factors possibly infl uencing the cesarean delivery rate that could not be controlled was the increasing emphasis in the United States over the study time period for preventing late preterm (34 -36 weeks of gestation) and early term (36 -38 weeks of gestation) births, many of which are iatrogenic. In practice, at our institution, this took the form of eliminating scheduled labor induction without adequate medical indications prior to 39 completed weeks of gestation. Because scheduled labor induction, particularly in the setting of an unripe cervix, is associated with an increase in the cesarean delivery rate, this is a change over time that may have also lowered the cesarean delivery rate, although the overall incidence of these scheduled inductions without medical indications below 39 weeks is comparatively low. The practice of limiting these scheduled inductions was begun in the year 2009, and we believe its effect, if there was any, is limited to the years of 2009 -2012. Considering the 50 % rise in overall cesarean delivery rates in the United States over the last decade to 32.8 % in 2010 [20] , it is an important goal of obstetric practice to avoid unnecessary cesarean deliveries, especially considering that there is a signifi cant positive association between cesarean delivery and maternal death [8] , as well as other adverse outcomes [11] .
Besides the implementation of the uniform low-dose oxytocin protocol, other aspects of the comprehensive safety program, such as team training, enhanced tracing reviews, and additional personnel could have had a positive impact on cesarean delivery rates.
Concerns about an increase in cesarean delivery rates after implementation of a comprehensive patient safety program including a standardized oxytocin protocol appear to be unfounded. Despite the US national increase in cesarean delivery rates, our study shows that it is possible to safely lower primary cesarean delivery rates without concomitant concerns of litigations. In our view, a uniform low-dose oxytocin protocol without using misoprostol in a live viable fetus is the keystone of improving patient safety without increasing cesarean delivery rates.
Our recommendation to implement a patient safety program which includes the use of a standardized low-dose oxytocin protocol [10] and highly specifi c protocols is supported by Hayes and Weinstein [13] as well as by Clark et al. [6] who recommended a standardized oxytocin protocol to improve patient safety.
Nearly 30 years ago, Seitchik and Castillo [23] commented on an important aspect of labor and delivery care: " Patients managed by a specifi c regimen and a computer-defi ned therapeutic goal had oxytocin stopped or the dosage reduced because of concerns with fetal distress, or, less frequently, hypercontractility, had shorter intervals from the initiation of oxytocin to full dilatation, required smaller doses to accomplish cervical change, and received smaller maximum incrementation of the oxytocin dose. The most signifi cant factor determining these results was the rate of incrementation of the oxytocin dose " .
Instituting a comprehensive patient safety program including a standardized low-dose oxytocin protocol should be considered by all obstetric units, not only because it can increase patient safety and decrease exposure to professional liability claims [12] , but also because it may avoid unnecessary cesarean deliveries and with it the proven risks of repeat cesarean deliveries in future pregnancies.
